Form 8-K - Current report:
SEC Accession No. 0001104659-25-001711
Filing Date
2025-01-07
Accepted
2025-01-07 17:00:29
Documents
16
Period of Report
2025-01-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm252048d1_8k.htm   iXBRL 8-K 39886
2 EXHIBIT 10.1 tm252048d1_ex10-1.htm EX-10.1 92491
3 EXHIBIT 99.1 tm252048d1_ex99-1.htm EX-99.1 17253
7 GRAPHIC tm252048d1_ex99-1img001.jpg GRAPHIC 8933
  Complete submission text file 0001104659-25-001711.txt   370859

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ganx-20250106.xsd EX-101.SCH 3039
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ganx-20250106_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ganx-20250106_pre.xml EX-101.PRE 22375
18 EXTRACTED XBRL INSTANCE DOCUMENT tm252048d1_8k_htm.xml XML 3798
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 25515582
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)